Personalized Medicine Market

Personalized medicine sales will grow through 2036, with diagnostics remaining central as biomarker testing, genomic profiling, and companion diagnostics guide treatment selection. Therapeutics gain traction as targeted oncology, immunology, and gene-based treatments move deeper into clinical use. The market is expected to reach USD 419.1 billion in 2026 and USD 779.4 billion by 2036.